Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_assertion type Assertion NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_head.
- NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_assertion description "[Significantly increased frequencies of HLA-DR3 (36% vs 5%), HLA-DR7 (9% vs 4%), HLA-DR11 (36% vs 7%) and HLA-DRw53 (23% vs 5%) were observed in SSc-RA compared with RA patients (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_provenance.
- NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_assertion evidence source_evidence_literature NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_provenance.
- NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_assertion SIO_000772 17384178 NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_provenance.
- NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_assertion wasDerivedFrom befree-20140225 NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_provenance.
- NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_assertion wasGeneratedBy ECO_0000203 NP922670.RAIpF3vQ-d3pXb3EkLOcPRiOGyoMp5W5YTchcMhko2F6A130_provenance.